GSK to buy US cancer biotech Nuvalent for $10.6bn
Home - Financial Times [Unofficial]
June 9, 2026
New chief Luke Miels makes his mark at GSK with one of UK drugmakers’ biggest deals
Discussion in the ATmosphere